Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2026
Hernia recurrence postconcurrent hernia repair and metabolic and bariatric surgery versus ventral hernia repair alone.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Binte Mohd Kamil Siti Humaira, Masuda Yoshio, Lee Piea Peng, Jin Lee Zhen, Eng Alvin, Lim Eugene, Chan Weng Hoong, Tan Jeremy, Tan Sarah, Chang Tan Hong, Ho Emily, Kovalik Jean-Paul, Goh Orlanda, Sim Jacqueline, Lee Phong Ching, Lim Chin Hong
Аннотация
BACKGROUND: In patients with obesity and ventral hernias, there is growing interest in combining ventral hernia repair with metabolic and bariatric surgery (MBS) as a concurrent procedure. This reduces anesthetic exposures and decreases costs associated with separate surgeries.
OBJECTIVES: This study aims to evaluate the safety and efficacy of concurrent ventral hernia repair and MBS compared to ventral hernia repair alone.
SETTING: University Hospital.
METHODS: A single-center, retrospective study was conducted on 174 patients treated with either ventral hernia repair alone or concurrent ventral hernia repair with MBS from January 2016 to December 2023. There was no loss to follow-up. A propensity-score matched analysis was performed, and 6 characteristics were selected as covariates (age, gender, race, preoperative body mass index, hernia defect size, smoking history and diabetic status). Separate univariate analyses were conducted to determine if outcomes differed by surgical approach.
RESULTS: Treated patients undergoing concurrent surgery were less likely to experience hernia recurrence (OR = .114, 95% CI .062-.21, P < .001) compared to those receiving hernia repair alone. They also had a lower likelihood of complications such as seromas and stitch granulomas (OR = .362, 95% CI .167-.783, P = .01).
CONCLUSION: Concurrent ventral hernia repair with MBS is a safe and effective option for patients with obesity and ventral hernias. It demonstrates comparable rate of short-term perioperative complications and offers long-term advantages, including reduced rates of hernia recurrence.
OBJECTIVES: This study aims to evaluate the safety and efficacy of concurrent ventral hernia repair and MBS compared to ventral hernia repair alone.
SETTING: University Hospital.
METHODS: A single-center, retrospective study was conducted on 174 patients treated with either ventral hernia repair alone or concurrent ventral hernia repair with MBS from January 2016 to December 2023. There was no loss to follow-up. A propensity-score matched analysis was performed, and 6 characteristics were selected as covariates (age, gender, race, preoperative body mass index, hernia defect size, smoking history and diabetic status). Separate univariate analyses were conducted to determine if outcomes differed by surgical approach.
RESULTS: Treated patients undergoing concurrent surgery were less likely to experience hernia recurrence (OR = .114, 95% CI .062-.21, P < .001) compared to those receiving hernia repair alone. They also had a lower likelihood of complications such as seromas and stitch granulomas (OR = .362, 95% CI .167-.783, P = .01).
CONCLUSION: Concurrent ventral hernia repair with MBS is a safe and effective option for patients with obesity and ventral hernias. It demonstrates comparable rate of short-term perioperative complications and offers long-term advantages, including reduced rates of hernia recurrence.